Dr. Wa'El Jamal Kamel Tuqan, MD

Dr. Tuqan practices at CHI St. Vincent Infirmary in Little Rock, Arkansas, part of CommonSpirit Health.

Dr. Tuqan's NPI, 1346620606, was assigned on June 2, 2015. Dr. Tuqan holds Arkansas license E-13671.

Dr. Tuqan's primary practice is CHI St. Vincent Infirmary, at Two St Vincent Circle, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 552-3000. Dr. Tuqan also practices at Chi St Vincent Infirmary Medical Center, 2 St Vincent Cir, Little Rock, AR 72205.

Dr. Tuqan's primary practice is CHI St. Vincent Infirmary in Little Rock, Arkansas, part of CommonSpirit Health. Dr. Tuqan is also affiliated with Halifax Health Medical Center of Daytona Beach. The medical group on file is CHI St. Vincent Medical Group. Dmand AI also links Dr. Tuqan to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tuqan practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Tuqan's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Tuqan is licensed in Arkansas.

CMS data shows 2,099 Medicare services from Dr. Tuqan across 20 procedure codes in 2024, for 511 Medicare patients. Medicare paid $199,231 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 511 Medicare patients who saw Dr. Tuqan in 2024. The largest group is 75 to 84, with 181 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tuqan's median patient age at 72, with 55% women.

In 2024, Dr. Tuqan wrote 87 Medicare Part D claims for 64 patients. 76% of them were for generic drugs. CMS names the drug for 61 of them, across 3 drugs with 11 or more claims each, at $1,106 in total drug cost. In 2020, CMS named 14 claims across 1 drug.

Dr. Tuqan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 569 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Tuqan, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Tuqan, published from 2015 to 2022. 2015 was the busiest year, with 2. Dr. Tuqan has published most often in Dig Dis Sci. Dr. Tuqan's most frequent co-authors are Ayoub Innabi, MD, Kamelah Ali Suleiman Abushalha, MD and Maan Elkhatib, MD.

CMS Open Payments shows 11 general payments to Dr. Tuqan from 5 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $602.